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The apical membrane of renal proximal tubular epithelial cells is the main controller of phosphate
homeostasis, because it determines the rate of urinary Pi excretion. The opossum kidney (OK)
cell line is a good model for studying this function, but only NaPiIIa (NaPi4) has been identified
to date as a Pi transporter in this cell line. In this work, we have identified three additional
Pi transporters that are present in OK cells: NaPiIIc, PiT1 and PiT2. All three sequences are
similar to the corresponding orthologues, but PiT1 is missing the first transmembrane domain.
Confluent cells exhibit characteristics of type II Pi transport, which increases with alkalinity and is
inhibited by phosphonoformic acid (PFA), and they mainly express NaPiIIa and NaPiIIc, with a low
abundance of PiT1 and PiT2. Proliferating cells show a higher expression of PiT1 and PiT2 and a
low expression of NaPiIIa and NaPiIIc. Adaptation to a low Pi concentration for 24 h induces the
expression of RNA fromNaPiIIa andNaPiIIc, which is not prevented by actinomycinD. Small inter-
fering RNA transfections revealed that PiT1 is not necessary for Pi transport, but it is necessary
for adaptation to a low Pi, similar to NaPiIIa and PiT2. Our study reveals the complexity of the
coordination between the four Pi transporters, the variability of RNA expression according to
confluence and the heterogeneous correlation between Pi transport and RNA levels.
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1 INTRODUCTION
Inorganic phosphate homeostasis is achieved through the coordinated
activity of intestinal absorption, bone storage and the renal excretion
of surplus Pi (for reviews, see Biber, Hernando, & Forster, 2013;
Chang & Anderson, 2017; Marks, Debnam, & Unwin, 2010). These
three processes are the targets of a number of hormonal and non-
hormonal regulatorymechanisms, which apparently act in a redundant
manner. The evolutionary cost of the existence of so many regulatory
mechanisms is justified not only by the physiological relevance of
inorganic phosphate but also by the dangerous outcomes of Pi
homeostasis dysregulation and toxicity (e.g. Chang & Anderson, 2017;
Komaba & Fukugawa, 2016).
Of the aforementioned three processes, renal reabsorption/urinary
excretion of Pi is recognized as the main and fastest mechanism for
achieving phosphate homeostasis, and it is a target of all regulators
known to affect Pi homeostasis. Most renal Pi reabsorption takes
place in the proximal tubule through the activity of sodium-coupled Pi
cotransporters expressed in theapicalmembraneof theepithelial cells.
c© 2018 The Authors. Experimental Physiology c© 2018 The Physiological Society
Two type II Pi transporters, NaPiIIa and NaPiIIc (Forster & Werner,
2018; Forster, Hernando, Biber, & Murer, 2013), and two type III Pi
transporters, PiT1 and PiT2 (Forster et al., 2013; Sorribas, 2018), are
expressed in the proximal tubule. However, only NaPiIIa, NaPiIIc and
PiT2 have been described in the apical brush-border membrane, and
they are regulated by dietary Pi deprivation in different ways (Villa-
Bellosta et al., 2009b). Therefore, in addition to the activity of many
regulatory mechanisms, the presence of several Pi transporters that
are not regulated in a similar manner further complicates our ability
to understand this important homeostatic function precisely.
For study of the cellular and molecular mechanisms of Pi
reabsorption, the most common in vitro model is the opossum kidney
(OK) cell line. In this line, factors such as the kinetic characteristics of
Pi transport (including the response to pH changes), the regulation
by parathyroid hormone and the Pi concentration in the culture
medium, and the expression of NaPiIIa are similar to the responses
and characteristics observed in the proximal tubule (e.g. Malmström
&Murer, 1986; Sorribas et al., 1994). Nevertheless, although OK cells
have helped us to understand some of the molecular mechanisms of
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NaPiIIa regulation, they represent a limited cell model, both because
this model lacks a genome sequence of the original species (Didelphis
virginiana) and because of the scarcity of commercial antibodies. In
this respect, the various groups that are working in this area have
been unable to generate functional and valid antibodies against the
endogenous NaPiIIa (formerly NaPi4). One exception is Professor
Lederer's group, which was able to generate a functional polyclonal
antibody (Lederer, Sohi, Mathiesen, & Klein, 1998).
In this work, we have attempted to overcome the aforementioned
limitations regarding the use of OK cells when studying renal tubular
proximal Pi transport. Although the only Pi transporter that had been
identified and sequenced in these cells up to nowwasNaPiIIa (Sorribas
et al., 1994), we have now been able to sequence the three other
types of sodium-coupled Pi transporters in the kidney known to date:
NaPiIIc, PiT1 and PiT2. Sequences were analysed in silico for two-
dimensional (2D) modelling, and the various expressions of the four
transporters were also studied as a function of culture confluence and
the concentration of Pi in the medium. The expressions were contra-
sted with the characteristics of the resulting transport, in combination
with RNA interference, subsequently leading us to reach conclusions
about the relevance of each transporter in the total Pi uptake by these
cells.
2 METHODS
2.1 Cell culture and transport assays
Opossum kidney proximal tubule (OK) cells, a permanent cell line
originally obtained from a female American opossum kidney (Koyama,
Goodpasture, Miller, Teplitz, & Riggs, 1978), were grown in Dulbecco's
modifiedEagle'smedium (DMEM)–Ham's F12 supplementedwith10%
fetal calf serum (FCS), penicillin, streptomycin and L-glutamine at 37◦C
in air supplemented with 5% CO2. At confluency, cells were made
quiescent by incubating them in the samemediumwith FCS at 0.2% for
24 h. For various Pi concentrations in the culturemedia, Pi-freeDMEM
with 0.2% FCSwas used, which was ultimately supplemented with 0.1,
1 or 2 mmol l−1 Pi (from a combination of K2HPO4 and KH2PO4 for
a final pH of 7.4). All culture reagents were from Gibco (Thermofisher
Scientific,Waltham,MA, USA).
Transport assays were performed on plastic support, as described
(Sorribas et al., 1994; Villa-Bellosta & Sorribas, 2009). 32P-H2PO4 was
used as a radiotracer at 5 𝜇Ci ml−1 in uptake media (PerkinElmer,
Waltham,MA, USA).
2.2 Rapid amplification of complementary
DNA ends (RACE)
For the identification and subsequent sequencing of OK cell
complementary DNA (cDNA), we used an RNA ligase-mediated,
rapid amplification procedure of 5′ and 3′ ends of cDNA with a
GeneRacer kit from Invitrogen (Thermofisher Scientific), following
the manufacturer's instructions. For amplification, gene-specific
primers were designed from a consensus region of aligned sequences
of Monodelphis domestica, Mus musculus, Rattus norvergicus and
NewFindings
• What is the central question of this study?
The opossum kidney (OK) cell line is the main in vitro
model of proximal tubular Pi transport, but it is incomplete
because only the NaPiIIa Pi transporter has been
identified.
• What is themain finding and its importance?
We have cloned and characterized the Pi transporters
NaPiIIc, PiT1 and PiT2 from OK cells and have analysed
the relevance of the four transporters to Pi transport. All
four transporters are involved in the upregulated Pi trans-
port of cells incubated using a low-Pi medium, and only
PiT1 is not involved in basal transport.
Homo sapiens to generate overlapping 5′ and 3′ ends of cDNA.
The sequence analysis and assembling were carried out using
MacVector v.14.0 (MacVector, Inc, Cary, NC, USA). The sequences
of NaPiIIc, PiT1 and PiT2 obtained from Didelphis virginiana were
reported to GenBank (http://www.ncbi.nlm.nih.gov/Genbank/
index.html) with the accession numbers MH397475, MH397476
andMH397477, respectively.
2.3 Pharmacological treatments
All chemicals were from Sigma-Aldrich (St Louis, MO, USA). Quiescent
OK-P cellswere incubated for 24h in the presence or absence of either
1 𝜇mol l−1 actinomycin D or 0.01 𝜇mol l−1 triiodo-L-thyronine (T3) and
different concentrations of Pi. Reagents were dissolved in dimethyl
sulfoxide (DMSO), and the same amount of solvent was added to the
control cells (0.1% final concentration; i.e. 1:1000 dilution).
2.4 RNA interference
All reagents for RNA interference and transfection were from
Ambion (Thermofisher Scientific). Validated small interfering RNAs
(Silencer Select siRNAs) were transfected using a final concentration
of 10 nmol l−1 according to the manufacturer's instructions. Cells
were incubated for 24 h with Lipofectamine RNAiMAX, and the
corresponding RNAis in OPTIMEM. Subsequently, the medium was
replaced with DMEM–F12, supplemented with 10% FCS, and the cells
were incubated for an additional 48 h until the corresponding assay
was performed. Real-time PCR revealed that maximal reduction of the
target RNAs in OK cells was observed after 48 h. A scrambled siRNA
with a similar base composition was used as a negative control.
2.5 Real-time PCR
Total RNA was purified from OK cells using Quick-RNA MiniPrep
(Zymo Research, Irvine, CA, USA), and it was treated with DNase I.
Total RNA was retrotranscribed using a PrimeScript RT Reagent Kit
(Perfect Real Time) (Takara Bio Inc., Kusatsu, Japan) and amplified in a
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TABLE 1 Primers used in qPCR
Gene name Protein name Accession Sequences Amplicon size (bp)
SLC34A1 NaPi-IIa (NaPi4) L26308 CTTGTCTAATCCTGTGGCTGGT
ATGCTGACGATGATGGAGGTAG
93
SLC34A3 NaPi-IIc XM_007475446 GCTCTGGAAAAACTCAGTGGTC
TCTAGCTGCACAATGAGATGGG
119
SLC20A1 PiT-1 XM_007477571.1 TTCTGTTGTACGGTGGCGTT
ATGCAATGACTACGGTGAGAGC
150
SLC20A2 PiT-2 XM_007476411.1 GGGGCACCAGTATTAGGTTTGA
TCTTGATAGGGCACCCTCTTTC
159
GADPH GADPH DQ403044 TCCTGCACTACCAACTGCTT
AAGCAGGGATGATATTCTGGGC
177
BETA-ACTIN 𝛽-actin AY944136 AAGAAATCACAGCCCTGGCA
GAAGCCAGAATAGAGCCACCAA
100
LightCycler 1.5 (Roche, Mannheim, Germany) using a SYBR Premix Ex
Taq II (Takara). The primers used are shown in Table 1. Gene expression
data were normalized to an endogenous reference (GADPH) and to a
calibrator according to themanufacturer's instructions.
2.6 Cell membrane preparation and immunoblot
analysis
After treatments, cells grown in 100 mm dishes were scraped into
5 ml of ice-cold PBS and centrifuged at 15000g for 10 minutes. The
cell pellet was resuspended in 1 ml of buffer [20 mmol l−1 Tris–HCl
(pH 7.5), 2 mmol l−1 MgCl2, 250 mmol l
−1 sucrose and proteinase
inhibitors; Roche Diagnostics] and was kept on ice for 15 min. Cells
were then passed through a 22-gauge needle 20 times, and the cell
debris was separated by centrifugation at 1000g for 10 min at 4◦C.
The supernatant was recentrifuged at 30,000g for 90 min at 4◦C,
and the cell membrane pellet was resuspended in 100 𝜇l of lysis
buffer [50 mmol l−1 Tris–HCl (pH 8.0), 80 mmol l−1 NaCl, 2 mmol l−1
CaCl2 and 1% Triton X-100 or 1% CHAPS], with the same proteinase
inhibitors.
The protein concentration was determined using a BCA kit
(Pierce, Thermofisher Scientific). Twenty-five micrograms of protein
were separated by SDS-PAGE at 10% for 150 min at 100 V in a
Miniprotean cell (Bio-Rad, Hercules, CA, USA). Proteins were trans-
ferred electrophoretically onto polyvinylidene difluoride membranes
(Bio-Rad) using a Trans-Blot Turbo Transfer System (Bio-Rad)
according to the manufacturer's instructions. Membranes were
incubated overnight with the primary antibodies at 4◦C. After
incubation with a secondary antibody linked to horseradish
peroxidase, the reactionwas developed using the Luminata Crescendo
(Millipore, Billerica, MA, USA), and the image was captured and
analysed using the Versadoc Image System (Bio-Rad).
Polyclonal antibodieswereprepared in rabbits by injecting peptides
conjugated to keyhole limpet haemocyanin and mixed in Freund's
complete adjuvant (Davids Biotechnologie, Regensburg, Germany).
The following peptides were used:
(i) NaPiIIc: SPDQEEEGEADPWALPQLKTS. The sequence
corresponds to amino acids 39–59, which are located in the
intracellular compartment, before the first transmembrane
domain.
(ii) PiT1: EKKSSLKEDHEEAKLSLGDGE, corresponding to amino
acids 269–289, a peptide located at the beginning of the large,
central intracellular loop [between transmembrane domains
(TMDs) VI and VII].
(iii) PiT2: HKDSGLYKDLLHKIHLDRGPD, corresponding to amino
acids 348–368, also located in the middle of the large, central
intracellular loop.
None of these antibodies provided reliable specific signals, either
after the quality controlswith pre-immune serumandpeptide blocking
or after the optimizations with different dilutions and detergents.
Therefore, no results are shown. However, for NaPiIIa (formerly,
NaPi4), a polyclonal antibody was generously donated by Professor
Eleanor Lederer (University of Louisville School of Medicine, KY, USA)
andwas used as a control for the indicated experiments.
2.7 Statistics
All experiments were repeated three times, using triplicates per
condition, and are shown as means ± SD. GraphPad Prism 5.0
(GraphPad Software, La Jolla, CA, USA) was used for statistical
analysis. The significances of differenceswere determined by unpaired
Student's t test or by one-way ANOVA with Tukey's post hoc test for
multiple comparisons, depending on the experiment and the number
of means. Differences were considered significant when the P values
were< 0.05.
3 RESULTS
3.1 Cloning of PiT1, PiT2 andNaPiIIc fromOK cells
RACE assays provided the complete coding region sequence of PiT1
(677 amino acids) and PiT2 (653 amino acids). In the case of NaPiIIc,
only the 5′-RACE was obtained, which included the first 422 amino
acids. A 2D model of PiT1 is shown in Figure 1a, with several common
and uncommon characteristics revealed after an alignment with
various orthologues. Common characteristics include a glycosylation
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F IGURE 1 Structural two-dimensional model of PiT1 and PiT2 from opossum kidney (OK) cells. The complete amino acid sequences are shown.
(a) PiT1 is outlined in an 11-transmembrane domain (TMD)model, beginning at an intracellular amino-terminus. TheN-glycosylation site at N94 in
the first extracellular loop and two phosphorylation sites at S261 and S265 in the large intracellular loop are also shown. Two phosphate
transporter family domains, pfam01384 (PHO4), are shown in blue amino acid residues, encompassing amino acids 43–140 and 561–659. The
extracellular region between TMDs 1 and 2 (a, in green box) contains several residues involved in Pi transport and affinity. (b) Alignment of the
first 42 amino acids (b, also in green box) with the N-termini of several orthologues. The red dashed box indicates the first common TMD, which is
not present in OK cells. (c) A hydropathy Kyte/Doolittle analysis of the first 42 amino acids of PiT1 fromOK cells is shown and comparedwith the
same terminus of the human orthologue, which reveals the high hydrophilicity of theOK amino-end sequence. (d) Two-dimensional model of PiT2,
with the accepted 12 TMDs and both protein ends located extracellularly. All annotations are as for PiT1
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F IGURE 2 Structural two-dimensional model of NaPiIIc fromOK cells. Given that only the first 422 amino acids were identified, purely for the
purpose of modelling, the remaining amino acids, 423–621 (letters in red), were copied fromMonodelphis domesticus. This two-dimensional model
was developed from the proposed three-dimensional structure of NaPiIIa (Fenollar-Ferrer et al., 2014). RU1 and RU2 are repeated structural
units that constitute the transport core of the protein. Proposed intra- or extramembrane helices are numbered from 1 to 8. Former re-entrant
repeats are now depicted as hairpins 1a, 1b, 2a and 2b. Transmembrane helices 2 and 5 are divided by non-helical intramembrane loops L2ab and
L5ab. The last two TMDs (7 and 8) are not a part of the repeated core. Red arrows indicate amino acids that determine the electrogenicity in Slc34
Pi transporters: GSG in electroneutral NaPiIIc and AAD in electrogenic NaPiIIa
site at asparagine N94 within the first extracellular loop (amino acids
83–96); two phosphorylation sites at S261 and S265 in the main
intracellular loop; and two phosphate transporter family domains
(pfam01384) at amino acids 43–140 and 561–659, respectively
(PHO4; https://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=
pfam01384). The first loop (amino acids 83–96) is a region involved
in Pi affinity and, according to the results of a combination of the
two-electrode voltage clamp and substituted cysteine accessibility
methods, this region seems to form part of a hydrophilic pore where
the substrates interact with specific amino acids (Ravera, Murer, &
Forster, 2013).
A hydropathy analysis revealed an uncommon structure of 11
TMDs, with the amino end located intracellularly and the carboxy
terminus located extracellularly. This contrasts with the established
12-TMD model, in which both ends of the protein are located
extracellularly (Bøttger & Pedersen, 2011; Ravera et al., 2013). The
11-TMD proposal is attributable to the absence, in OK cell PiT1,
of the first accepted TMD of the 12-TMD model, which has the
consensus sequence ILGFIIAFVLAFSVG in the other orthologue
proteins (Figure 1b). This figure also shows the alignment of the first
42 amino acids of OK PiT1 with several orthologues, in addition to
a Kyte/Doolittle hydropathy analysis that compares those OK PiT1
amino acids and Homo PiT1 amino end sequences (Figure 1c). Seven
other tests provided similar hydropathy profiles using MacVector
software and protocols for hydrophilicity and hydrophobicity (not
shown).
PiT2 fromOKcells shows amore conserved structure, including the
12 TMDs and both ends located extracellularly, with N-glycosylation
located at N81, six potential phosphorylation sites in the large intra-
cellular loop and the two pfam01384 domains (Figure 1d).
For the 2D modelling of NaPiIIc, the sequence of the 422 amino
acids identified with 5′-RACE was fused in silico to amino acids 423–
621 from M. domestica (accession no. XP_007475507). The added
sequence is shown as red residues in Figure 2. A hydropathy analysis
of the resulting chimeric protein provided the classical 12-TMDmodel
(Forster, Hernando, Biber, & Murer, 2012). A more recent work has
suggested a very interesting three-dimensional (3D) model of NaPiIIa
(Fenollar-Ferrer et al., 2014) based on hydropathic, fold homology
with the Na+-coupled dicarboxylate transporter from Vibrio cholerae
(Mancusso, Gregorio, Liu, & Wang, 2012). We have not developed
a 3D model for OK NaPiIIc because it is beyond the scope of this
work andbecauseour sequenceofNaPiIIc is incomplete.Nevertheless,
Figure 2 shows a combination of a 2D model of NaPiIIc with several
modifications andcharacteristics derived fromthe3Dmodel ofNaPiIIa
(Fenollar-Ferrer et al., 2014). In thismodel, both the amino and carboxy
ends are still located intracellularly, and a large, central extracellular
loop containing three N-glycosylation sites divides the protein into
two parts, each one containing a repeated structural unit (amino acids




F IGURE 3 Pi transport in confluent OK cells. (a) Pi uptake in cells incubated for 24 hwith either 0.1 or 2.0mmol l
−1 Pi, and as a function of pH.
The pH dependence is shownwith the corresponding regression lines for both Pi concentrations. The dashed line indicates the level of
Na+-independent uptake. Asterisks indicate significantly different means by unpaired Student's t test (P< 0.05). (b) Effect of 5mM
phosphonoformic acid (PFA) on total Pi uptake at either pH 6.0 or 8.5 in cells incubated as in (a). Asterisks indicate significantly different means by
ANOVA and amulticomparison post hoc test (P< 0.05)
68–227 for RU1 and amino acids 332–496 for RU2, respectively). As
in the case of NaPiIIa, these units would constitute the transport core
of NaPiIIc. The model contains eight TMDs, with additional membrane
domains now considered to be hairpins 1 (a,b) and 2 (a,b), which were
formerly considered re-entrant repeats. Transmembrane domains 2
and 5 are complex structures, each one divided into two domains (a
andb) bynon-helical intramembrane loopsL2abandL5ab.Glycine196,
serine 198 and glycine 202, which mandate electroneutral activity
in NaPiIIc and are respectively replaced in NaPiIIa by A, A and D
to provide electrogenicity, are indicated by the three red arrows in
RU1 (Patti, Ghezzi, & Forster, 2013). The last two complete TMDs, 7
and 8, mainly contribute to the 3D structure. The carboxy terminus
of M. domestica also includes a binding site (SQRL) for PDZ domain-
containing proteins, such as NHERF3PDZK1 (Villa-Bellosta et al., 2008).
3.2 Relevance of type II versus type III Pi transport
Beginning with a concentration of 1 mmol l−1 Pi, OK cells were
incubatedwith 0.1 or 2mmol l−1 Pi in DMEM for 24 h. Figure 3a shows
that, as expected, the uptake of OK cells incubated with 0.1 mmol l−1
Pi was twice the uptake with 0.05 mmol l
−1 32Pi at pH 7.4 compared
with cells maintained in DMEM with 2 mmol l−1 Pi. The activity of
the type II and III Pi transporters is very sensitive to the pH of the
medium because they preferentially transport HPO4
2− or H2PO4
−,
respectively, and because the relative abundance of these Pi species is
mainly dependent on the pH. In fact, at pH7.5monovalent Pi (H2PO4
−)
is ∼17%, whereas divalent Pi (HPO42−) is ∼83%. The effect of protons
as competitors with the sodium binding sites has also been suggested
(Hartmann et al., 1995). To study the uptake of each species more
specifically, the same type of experiment was performed at pH 6.0 and
8.5, given that at pH 6.0, 86% of Pi is H2PO4
−, whereas at pH 8.5, 98%
of Pi is HPO4
2− (see Candeal, Caldas, Guillén, Levi, & Sorribas, 2017).
The uptake at pH 6.0 was approximately 20–40% of the uptake
at pH 8.5, at either concentration of Pi, thereby showing the known
preference of OK cells for divalent Pi (Figure 3a). To emphasize the
linearity of the pH effect on Pi uptake, the regression lines of Pi uptake
as a function of pH are also shown for both Pi concentrations, and
they reveal no saturation at the pH range of the experiment. At all
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three pH values, the uptake of 0.05 mmol l−1 32Pi was approximately
double in cells adapted to 0.1 mmol l−1 Pi, compared with 2 mmol l
−1
Pi. Given that type III Pi transporters (PiT1 andPiT2) have a preference
formonovalent Pi and that type II Pi transporters (NaPiIIa andNaPi2c)
have a preference for divalent Pi, the pH results suggest that in OK
cells and our experimental conditions, type II activity is double that of
type III at 0.05 mmol l−1 Pi. However, the results also show that the
adaptation of type III Pi transport also takes place to the same extent
as type II.
To confirm these conclusions anddiscard thepresenceof additional,
unknown Pi transporters, we also used 5 mmol l
−1 phosphonoformic
acid (PFA) as an inhibitor of type II transporters (Figure 3b). At pH 6.0,
thepresenceofPFAdidnot significantly inhibit Pi uptake, but at pH8.5,
PFA completely prevented adaptation to incubation with 0.1 mmol l−1
Pi for 24 h, and it maintained the uptake at the basal level of
2mmol l−1 Pi.
3.3 Basal mRNA expression of Pi transporters
The mRNA expression of the various Pi transporters was also assayed
to test the predictions of the functional assays summarized in the pre-
ceding section. In basal conditions (i.e. 100% confluent OK cells grown
in DMEM–F12 medium), NaPiIIa and NaPiIIc were the most abundant
Pi transporters, and PiT2 was the least-expressed RNA (Figure 4a).
This general expression pattern was maintained in cells incubated in
Pi-deprivedmedium (0.1mM) for 24 h, and it only showed an increased
expression of NaPiIIa and NaPiIIc over type III transporters (see
below). Before confluence (i.e. when the cells were proliferating), the
most abundant transporter was always PiT1. Only when the cells were
close to confluence (80%) did the expression of NaPiIIa and NaPiIIc
begin to be significant. The results of the expressions at different
confluent states are summarized in Figure 4b, where the expressions
are represented on a logarithmic scale owing to the several-fold
changes in expression as a function of culture confluence. This high
variability in the expression of transporters with confluence should be
considered to avoid anymisinterpretation of the results.
3.4 Role of RNA transcription in Pi adaptation
Next, we analysedwhether the adaptation to low Pi was dependent on
changes in RNA transcription. TheOK cells were incubatedwith either
0.1 or 2 mmol l−1 Pi for 24 h in the presence or absence of 1 𝜇mol l
−1
actinomycin D inDMSO (Figure 5). The same amount of solvent, with a
final concentration of 0.1%,was added to the control cells. To avoid the
repetition of previous reports, Pi transport activity was determined at
the pH 6.0 and 8.5 to facilitate a study of the effects on type III and
II Pi transport, respectively. Actinomycin D prevented the observed
increase in Pi transport with 0.1 mmol l
−1 Pi at pH 6.0 (i.e. when
PiT1 and PiT2 are more active and relevant), therefore suggesting
the dependence of these transporters on transcriptional activity. At
pH 8.5, however, when HPO4
2− and Pi uptake were at their highest,
the adaptation persisted despite the treatment with actinomycin D,
but transport activity was half the rate of cells without actinomycin D
treatment, whether incubated at 0.1 or 2mmol l−1 Pi.
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F IGURE 4 qPCR analysis of Na/Pi cotransporter RNA expressions
in OK-P cells in relationship to PiT2, which is the least abundant Pi
transporter. (a) Relative expressions in a culture at 100% confluence
on a linear scale, in cells incubated for 24 h in 0.1 or 1mM Pi. (b)
Expressions of the Pi transporters with respect to PiT2 at the
indicated percentages of confluence in cells grown in 1mM Pi. A
logarithmic scale on the ordinate axis is used owing to the high
number of expression time differences. PiT1 and PiT2 expressions
diminish andNaPiIIa and NaPiIIc expressions increase when theOK
cell culture is more confluent
3.5 Changes in RNA abundance during adaptation
to Pi concentrations in OK cells
To check whether the effects of actinomycin D on Pi transport were
attributable, at least in part, to changes in theRNAabundance of any of
the four transporters, the corresponding RNA levels were determined
by real-time PCR (Figure 6a). TheNaPiIIa RNA abundance increased in
cells incubated with 0.1 mmol l−1 Pi, and this increase was resistant to
actinomycin D; after 24 h of treatment, the abundance and adaptation
effectswere similar. TheNaPiIIc RNAexpressionwas also increased by
low phosphate, and this increase was also resistant to actinomycin D.
However, in the presence of the transcription inhibitor, actinomycin D,
the expression of NaPiIIc RNA was reduced by half in cells maintained
with either 0.1 or 2mmol l−1 Pi.
We could not find clear and significant increased expressions of
PiT1 or PiT2 RNAs. Nevertheless, these transcripts were the most
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Pi, mM: 
ActD: 
0.1 2.0 0.1 2.0 
- - + + 
0.1 2.0 0.1 2.0 
- - + + 
Pi, mM: 
ActD: 
F IGURE 5 Effect of inhibition of transcription on adaptation to low and high (0.1 and 2mmol l−1 Pi) phosphate concentrations at the indicated
pH. Actinomycin D (ActD) prevents adaptation to low Pi when Pi transport is measured at pH 6.0. However, at pH 8.5 the effect of transcription
inhibition on adaptation is not observed, although actinomycin D does reduce Pi uptake at both concentrations of Pi. Asterisks indicate
significantly different means by ANOVA (P< 0.05)
sensitive to actinomycin D treatment; PiT1 expression was reduced by
six times and PiT2 by 18 times.
Owing to the failure to obtain functional and reliable polyclonal
antibodies (see Methods), we only used an anti-NaPiIIa antibody from
OK cells donated by Professor Eleanor Lederer (Lederer et al., 1998).
We checked the correlation between the RNA and the protein of
NaPiIIa in cells that were incubated for 24 or 48 h with either 0.1 or
2 mmol l−1 Pi and actinomycin D (Figure 6b). At 24 h, actinomycin D
did not clearly modify the expression of NaPiIIa. However, after 48 h
the expression was reduced to one-third of the corresponding initial
expression, at both 0.1 and 2 mmol l−1 Pi, and a modest adaptation
persisted.
To confirm the accuracy of the determinations of RNA changes
shown in Figure 6a, the abundances of the four Pi transporter RNAs
were also measured after treating OK cells with 10 nmol l−1 triiodo-
L-thyronine (T3) for 24 h, as a positive control (Alcalde et al., 1999;
Sorribas,Markovich, Verri, Biber, &Murer, 1995). Figure6c shows that,
in the case of NaPiIIa and NaPiIIc, T3 induced 1.5 times the expression
of each transporter, whereas PiT1 and PiT2 were unaffected in these
cells.
3.6 Specific relevance of Pi transporters in basal Pi
transport in OK cells
Given that the effects of actinomycin D on Pi transport and the
adaptation thereof can also be attributable to inhibiting the expression
of many other proteins, such as regulators, receptors or scaffold
proteins, we selectively inhibited the expression of transporters by
using siRNAs (Figure 7). The efficiency of the interferences varied
considerably among the experiments, ranging from 70 to >90% after
48 h (Figure 7a). The percentages of inhibitions were similar, despite
the initial differences in transporter expressions. These expressions
were similar whether they were transfected with scrambled siRNAs
(Figure 7b) or were non-transfected (Figure 4; 100%). Even when
the cells were transfected in a culture at 80% confluence, the
cells were 100% confluent at the moment of the final assay owing
to the necessary incubation of the cells for 48 h in DMEM–F12
supplementedwith 10%FCS. This explains the difference between the
RNA expressions of Figures 7b and 4b at 80% confluence.
The results of specific Pi transporter knockdown were absolutely
unexpected. Functional assays afterRNA interferencewereperformed
at different pH values to facilitate the interpretation of results. For
PiT1 and PiT2 siRNA transfections, Pi transport was measured at
pH6.0 after 48 h,whereas forNaPiIIa andNaPiIIc, an uptake assaywas
performed at pH 8.5. Despite the higher expression of PiT1 over PiT2,
siRNA inhibition of the expression of PiT1 did not cause any change in
Pi transport (Figure 7c). However, RNA expression inhibition of PiT2
caused a 39% reduction in Pi transport, despite the lower expression
of PiT2 comparedwith PiT1 and the other Pi transporters.
Regarding type II transporters, the results of inhibitionwere similar
for bothNaPiIIa andNaPiIIc (Figure 7d). Pi transport afterNaPiIIa kno-
ckdown was reduced by 65%, whereas the interference with NaPiIIc
resulted in a 59% reduction of Pi uptake. In the case of NaPiIIa, the
inhibition of RNA expression with siRNA was accompanied by a red-
uction of protein expression, as confirmed bywestern blot (Figure 7e).
3.7 Specific relevance of Pi transporters in OK
cell adaptation
To ascertain the role of the various Pi transporters in adapting to a
low or high Pi concentration in the culture medium, we transfected
the cells (80% confluence) with the various siRNAs, and after 48 h, the
cells were incubated with 0.1 or 2mmol l−1 Pi for 24 h. The apparently
unexpected results are shown in Figure 8. In all four cases, siRNA not
only prevented adaptation to low Pi (0.1 mmol l
−1), but it also further
reduced the uptake level in cells incubated with 2 mmol l−1 Pi. This
reduction below the level of 2 mmol l−1 Pi was significant only in the
case of NaPiIIa andNaPiIIc.
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F IGURE 6 qPCR analysis of RNANa/Pi transporter abundance in OK-P cells. (a) Effect on the abundance of the indicated Na/Pi cotransporter
RNAs after 24 h of incubation with a low or high Pi concentration andwith the transcription inhibitor actinomycin D (ActD). (b) Effect on NaPiIIa
protein expression, in relationship to 𝛽-actin, in the same conditions as in (a), for 24 and 48 h. (c) Effect of 10 nM triiodo-L-thyronine (T3) treatment
for 24 h on the relative expression of Pi transporters. Asterisks indicate significantly different means by ANOVA (P< 0.05)































F IGURE 7 Effects of NaPiIIa, NaPiIIc, PiT1 and PiT2 RNA interference on specific RNA abundance and basal Pi uptake. (a) Efficiency of siRNA
treatment on RNA abundance after 48 h of siRNA transfection against the indicated transporters using 80% confluent OK cells cultured in 1mM
Pi. Initial RNA abundances were as in Figure 3. (b) Relative expression of the four transporter RNAs after scrambled (SB) siRNA transfection. (c)
Resulting Pi transport after 48 h of siRNA transfection with scrambled, PiT1 or PiT2 siRNAs. Transport wasmeasured at pH 6.0 tomaximize
type III activity. (d) Resulting Pi transport after 48 h of siRNA transfection with scrambled, NaPiIIa or NaPiIIc siRNAs. The Pi transport was
measured at pH 8.5 tomaximize type II activity. (e) Immunoblot of NaPiIIa after 72 h of siRNA transfection. In all panels, asterisks indicate
significant difference with an unpaired t-test from the corresponding scrambled siRNA transfection
4 DISCUSSION
In thiswork,weprovidenewknowledgeabout the renalmechanismsof
proximal tubular Pi transport, and the new findings can be divided into
two main parts. First, we have identified the sequences of the missing
Pi transporters in OK cells (NaPiIIc, PiT1 and PiT2), and second, we
have studied the relevance of the various transporters to the total Pi
uptake in OK cells and during adaptation.
Molecular identification was done by rapid amplification of cDNA
ends. BLAST analyses of the amino acid sequences in combination
with hydropathy algorithms revealed 2D structures similar to those
accepted for the corresponding orthologues, with some exceptions.
The main difference was related to PiT1, because the first 39
amino acids were very different with respect to the remaining
orthologues, resulting in high hydrophilicity and low hydrophobicity of
the amino-terminus, according to the hydropathy results (Figure 1c).
Consequently, the first TMD of the accepted model of PiT1 in other
species is not predicted for OK cell PiT1, and therefore, the model
changes from12TMDs (Bøttger&Pedersen, 2011; Ravera et al., 2013)
to 11 TMDs.
All the other characteristics present in PiT1 and PiT2 from OK
cells have been described previously. This includesN-glycosylation and
critical amino acids for Pi transport in the external region between
TMDs 1 and 2 in PiT1 and TMDs 2 and 3 in PiT2 (Ravera et al.,
2013), in addition to the two pfam01384 domains, the PD1131
homology domains (Salaün, Gyan, Rodrigues, & Heard, 2002) and the
PiT signature sequences (Bøttger & Pedersen, 2011).
All three members of the type II family (Slc34a1, Slc34a2 and
Slc34a3) of Pi transporters also showed a similar primary structure,
and with respect to the secondary structure, a 12-TMD 2D model
has been consolidated over the years (for a review, see Forster
et al., 2012). The OK NaPiIIc does not seem to be an exception,
but this cannot be confirmed until the complete sequence is known,
given that we identified only the first 422 amino acids (Figure 2).
Merely for the purpose of representing the model, we combined
this sequence fragment with the corresponding amino acids from the
related marsupial,M. domestica. A hydropathy analysis of this chimeric
sequence yielded the 12-TMD model, but instead of representing the
model (any new knowledge would be insignificant), we decided to
acknowledge the first 3D model of a member of the Slc34 family
GUILLÉN ET AL. 159
NaPi2a siRNA 
0.1 mM  Pi  2.0 mM  Pi  
SB siRNA SB siRNA NaPi2a siRNA NaPi2a siRNA 
NaPi2c siRNA 
0.1 mM  Pi  2.0 mM  Pi  
SB siRNA SB siRNA NaPi2c siRNA NaPi2c siRNA 
PiT1 siRNA 
0.1 mM  Pi  2.0 mM  Pi  
SB siRNA SB siRNA PiT1 siRNA PiT1 siRNA 
PiT2 siRNA 
0.1 mM  Pi  2.0 mM  Pi  
SB siRNA SB siRNA PiT2 siRNA PiT2 siRNA 
F IGURE 8 Effects of NaPiIIa, NaPiIIc, PiT1 and PiT2 RNA interference on adaptation of Pi transport to low and high Pi concentrations in OK
cells after 72 h of siRNA transfections at pH 7.4. Abbreviation: SB, scrambled siRNA. Asterisks in the top two panels indicate significantly different
means by ANOVA (P< 0.05). Asterisks in the PiT1 and PiT2 panels indicate significant differences from all other conditions
(Fenollar-Ferrer et al., 2014). Someprevious TMDshave been replaced
by hairpins and intramembrane loops, while the last two TMDs are
maintained, but they are not a part of the repeated core. The function
of these two last TMDs is still unclear, but the intracellular cytosolic
domain anchors the protein to the cytoskeleton through PDZ domain
proteins.
Based on the amino acid sequences, we prepared polyclonal anti-
bodies for the new transporters, but none of them provided specific
and reliable signals in the western blot analysis. The determination of
NaPiIIc from OK cells has been reported previously using an antibody
raised against a peptide corresponding to the C-terminus of NaPiIIc
from M. domestica (Ito et al., 2010). The sequences of the C-ends of
both opossumNaPiIIc aremost probably very similar or even identical.
Nevertheless, because the C-terminus of the American opossum was
missing in our 3′-RACE and because we also lacked antibodies against
PT1 and PiT2, we decided to homogenize the results and focus on the
functional and RNA regulation of all four Pi transporters. A striking
characteristic of the OK culture is the great variability as a function of
the proliferation state and confluency (Figure 4). The more confluent
the cells are, the higher the expression of type II, whereas the converse
is true for type III, in which expression is lower to the extent that
confluency is greater. In confluent OK cells, the expression of PiT2 is
negligible, and in highly proliferating cells the expressions of NaPiIIa
and NaPiIIc are extremely low. The characteristics of Pi transport
in confluent OK cells are typical of the proximal tubule, i.e. type II
Pi transport, meaning that it is increased by an alkaline pH and is
inhibited by PFA (Figure 3). Only at pH 6.0, when the monovalent Pi
species is most abundant, is type III Pi transport revealed, which is
resistant to PFA inhibition (Figure 3b). At this confluent state, NaPiIIa
andNaPiIIc aremost abundant, but PiT1 is also significantly expressed
(Figure4),which is consistentwith the results in both figures; transport
characteristics and RNA expression.
In addition to NaPiIIa (e.g. Markovich et al., 1995; Pfister et al.,
1998; Thomas, Wagner, Biber, & Hernando, 2016; Villa-Bellosta &
Sorribas, 2009), adaptation to a low Pi concentration in a culture
medium also affects NaPiIIc RNA in OK cells (Figure 6). In the case of
NaPiIIa (Markovich et al., 1995) and most probably regarding NaPiIIc,
the increase inmRNAseems to be attributable to an increased stability
of RNA rather than increased transcription. We have also quantified
the abundance of NaPiIIc mRNA after treatment with T3, a hormone
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known to increase the abundance of NaPiIIa transcriptionally in OK
cells and in rats (Alcalde et al., 1999; Sorribas et al., 1995). The NaPiIIa
RNA increased as expected (Figure 6c), and the increasewas similar for
NaPiIIc but was absent in the case of PiT1 and PiT2.
With respect to the molecular mechanisms of chronic adaptation
to a low Pi concentration in culture medium, previous transport
assays had been performed at pH 7.4, and only the RNA of NaPiIIa
(NaPi4) was evaluated (e.g. Markovich et al., 1995). By inhibiting
transcription with actinomycin D, we have, in part, confirmed those
previous results. NaPiIIc and both PiT1 and PiT2 (mainly) are very
sensitive to actinomycin D treatment, and after 24 h their RNA levels
drop dramatically and prevent Pi transport adaptationwhenmeasured
at pH 6.0. These results strongly suggest that the half-life of NaPiIIa
RNA is the longest of all four transcripts.
Using siRNA, these conclusions were confirmed only in part. The
main problem with this technology is that, to reach acceptable trans-
fection efficiency, the OK cell culture needs to be non-confluent,
and the expression of Pi transporters will differ considerably from
the time of confluence, as we have shown. Moreover, not only does
siRNA prevent the initiation of nascent RNAs, but the final and steady-
state abundance of the specific transcripts is also affected. Taking
these limitations into account, the inhibition of the specific trans-
cripts revealed that Pi transport was not affected by PiT1 siRNA; that
PiT2 interference moderately affected Pi transport, despite the low
expression; and that NaPiIIa and NaPiIIc siRNAs strongly affected
Pi transport in a similar, although not completely (Figure 7). The
non-effect by PiT1 siRNA could be explained by the long half-life
of the protein, an issue that can be addressed only when a good
antibody is obtained. Also, PiT1 has additional functions, such as
proliferation/apoptosis (Beck et al., 2009; Kongsfelt, Byskov, Pedersen,
& Pedersen, 2014) and Pi sensing (Bon et al., 2018; Salaün et al.,
2002), and at least in vascular smooth muscle cells, the protein is also
expressed intracellularly (Villa-Bellosta, Levi, & Sorribas, 2009a).
The effects of siRNAswere also studied regarding the ability of cells
to adapt to the concentration of Pi in the culture medium. The siRNA
treatment affected the process of adaptation in all four cases, but with
important differences (Figure 8). NaPiIIa siRNA prevents adaptation
to 0.1 mmol l−1 of Pi when compared with scrambled siRNA-treated
cells incubated with 2 mmol l−1 Pi, but when compared with NaPiIIa
siRNA-treated cells incubated with 2 mmol l−1 Pi, adaptation persists.
The effect of siRNA on NaPiIIc was similar but more modest. The
PiT1 and PiT2 siRNAs also completely prevented the adaptation of
Pi transport to a low Pi concentration. Given that the expressions
of both transporters are very low, a likely explanation is that these
transporters have other functions in addition to Pi transport, as
indicated above.
To summarize, confluent OK cells show a combination of type II
and type III Pi transport, with major expression of NaPiIIa and NaPiIIc,
minor expression of PiT1 and negligible expression of PiT2. NaPiIIa,
NaPiIIc, PiT1 and PiT2 are all involved in the handling of Pi by
these cells, but they seem to have very different roles at the basal
transport rate and during increased transport induced by a low Pi
concentration.
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